iJOY Lio SS40000: Three-Tank Design E-Cigarette Review and Analysis

Jan.14.2025
iJOY Lio SS40000: Three-Tank Design E-Cigarette Review and Analysis
iJOY launches innovative three-tank e-cigarette, iJOY Lio SS40000, with adjustable ice and sweetness levels in the US market.

Special announcement:

This article is for internal industry communication only and does not make any recommendations for brands or products.

The images presented in this article are only used to depict facts and are not intended as advertisements for any products.

This article prohibits minors from accessing it.


 

iJOY recently launched a new e-cigarette model called the iJOY Lio SS40000, featuring a triple-pod design that allows for adjustable cooling and sweetness levels. The product has already hit the market in the United States.

 

iJOY Lio SS40000: Three-Tank Design E-Cigarette Review and Analysis
iJOY Lio SS40000 | Image source: worldvapeusa

 

Specifically, the product specifications of iJOY Lio SS40000 are as shown in the table below.

iJOY Lio SS40000: Three-Tank Design E-Cigarette Review and Analysis
iJOY Lio SS40000 Product Information | Design: Two to Supreme

 

The main feature of the iJOY Lio SS40000 e-cigarette is its three-pod system design. According to the manufacturer's website, the product includes a total of four ice levels and three sweetness options, allowing users to adjust both independently using two dedicated buttons.

 

In addition, the iJOY Lio SS40000 also features a 3D curved side screen, which can display battery level, e-liquid remaining amount, and monitor information such as ice level and sweetness level.

 

In December, Shenzhen Donghaoxing Technology Co., Ltd.'s e-cigarette brand Artery Vapor also launched a three-pod design e-cigarette, the Artery CL6 Sweet & Ice Control 50K, in the US market. This product also allows for adjusting the level of sweetness and ice. However, compared to the iJOY Lio SS40000, the Artery CL6 Sweet & Ice Control 50K has advantages in terms of the number of puffs and e-liquid capacity. (For more details, please refer to the article "Product | Three-pod design disposable e-cigarette launches in the US, offering adjustable ice and sweetness levels").

 

In the first half of 2024, iJoy has launched the e-cigarette iJoy Bar SD40000 in the United States, which has a capacity of 40,000 puffs. This product is among the first batch of e-cigarettes in the U.S. market to have a puff capacity of 40,000. Up to now, the performance of iJoy's e-cigarette products in terms of puff capacity has not seen any new breakthroughs. (For more details, please refer to "Product | iJoy launches 40,000 puff disposable e-cigarette in the U.S. with support for AI voice control")

 

The iJOY Lio SS40000 has landed on e-cigarette distributor websites such as vapesourcing, midwestgoods, and worldvapeusa, but is currently not available on the official iJOY website.

 


2Firsts will continue to monitor the performance and market trends of global e-cigarette products, providing the public with accurate and authoritative industry information.

 

2FIRSTS is a product column dedicated to providing readers with the latest information on new products in the tobacco industry. In order to collect and share first-hand information from the industry more broadly, 2FIRSTS welcomes readers to submit articles and share the latest products in the e-cigarette field with us.

 

If you have any unique insights or information, please feel free to contact us at info@2firsts.com at any time.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | KT&G Launches lil HYBRID 3.0 Misty Rosé Edition II in South Korea With Two Pink Finishes at 88,000 Won
Product | KT&G Launches lil HYBRID 3.0 Misty Rosé Edition II in South Korea With Two Pink Finishes at 88,000 Won
South Korean tobacco company KT&G launched the limited-edition lil HYBRID 3.0 Misty Rosé Edition II on September 30, 2026, following the original Misty Rosé Edition introduced in November 2025. The new release comes in two pink finishes, Bloom Rosé and Viva Rosé, each priced at 88,000 won. Both versions initially went on sale through the lil Store online shop and lil MINIMALIUM flagship stores. From October 7, Bloom Rosé became available at approximately 1,500 lil Station retail outlets nationwide. The release retains the existing lil HYBRID 3.0 hybrid heated tobacco platform, with changes focused on exterior design and distribution.
product
Oct.10
Product | JT Launches Three Autumn-Limited Ploom Tobacco Sticks in Japan Across EVO, MEVIUS and CAMEL Brands
Product | JT Launches Three Autumn-Limited Ploom Tobacco Sticks in Japan Across EVO, MEVIUS and CAMEL Brands
Japan Tobacco Inc. (JT) launched three limited-edition autumn tobacco sticks for its Ploom heated tobacco devices in Japan on October 16, 2026, under the EVO, MEVIUS and CAMEL brands. All three are regular tobacco variants with seasonal packaging. Each pack contains 20 sticks, priced at ¥620, ¥590 and ¥570, respectively, including tax. The products are compatible with all Ploom devices and are sold in limited quantities exclusively through the CLUB JT online store while supplies last.
product
Oct.20
South Korea Fully Reviews Nicotine-Analog and Nicotine-Free Vape Liquid Imports, With Over 99% From China and Chinese Supply-Chain Documents Under Scrutiny
South Korea Fully Reviews Nicotine-Analog and Nicotine-Free Vape Liquid Imports, With Over 99% From China and Chinese Supply-Chain Documents Under Scrutiny
Korea Customs Service has tightened import controls on nicotine-analog and nicotine-free e-cigarette liquids, placing the products under 100% document review and subjecting all e-cigarette liquid import declarations to pre-clearance ingredient analysis. As of September 20, 2026, South Korea had imported about 15 metric tons of nicotine-analog liquids, 99.99% from China, and about 316 metric tons of nicotine-free liquids, including roughly 315 metric tons, or 99.7%, from China. The measures follow South Korea's April expansion of its tobacco definition to include synthetic nicotine products and include new checks on Chinese manufacturing, transaction and export documentation.
Sep.24
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24
Japan Survey Finds 49.5% Would Cut Tobacco Use if Prices Rise, 64.6% Show Interest in Nicotine-Free Alternatives
Japan Survey Finds 49.5% Would Cut Tobacco Use if Prices Rise, 64.6% Show Interest in Nicotine-Free Alternatives
A September online survey commissioned by Japanese smoking-accessories company Lightec found that 49.5% of respondents would consider reducing tobacco use if prices rose further, while 25.1% would consider switching to cheaper brands and 14.5% would consider using or combining alternatives such as vapes and nicotine-free herbal sticks. Another 64.6% expressed some level of interest in such alternatives. The survey covered 1,088 respondents aged 20 to 70 and was conducted by a company that sells NICOLESS nicotine-free vaping and herbal-stick products, meaning its findings should not be treated as representative of Japan's smoking population.
DATA
Oct.12
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22